Papulopustular rosacea - discontinue if no improvement after 1 month

Adex gel is accepted onto the formulary as an option for patients only following poor response from other first / second line formulary choices

Lubiprostone course of treatment for constipation is 2 weeks. See NICE guidance for advice on when it may be considered.

May be initiated on the advice of palliative care specialist

The tablet can be crushed before intake and mixed with water.

The tablet can be crushed before intake and mixed with water.

The tablet can be crushed before intake and mixed with water.

The tablet can be crushed before intake and mixed with water.

The tablet can be crushed before intake and mixed with water.

Alkindi is accepted for cortisol replacement therapy of infants and young children with adrenal insufficiency where the hydrocortisone 10mg tablets cannot be used, either whole or halved, to administer the required dose.

For initiation in patients with COPD and bronchiectasis following a request from the specialist respiratory physiotherapy team.

RCHT Renal Team prefers Adoport brand of Tacrolimus

To be initiated for patients with COPD and bronchiectasis following a request from the specialist respiratory physiotherapy team.

RCHT Renal Team prefers Adoport brand of Tacrolimus

Alkindi is accepted for cortisol replacement therapy of infants and young children with adrenal insufficiency where the hydrocortisone 10mg tablets cannot be used, either whole or halved, to administer the required dose.

Alkindi is accepted for cortisol replacement therapy of infants and young children with adrenal insufficiency where the hydrocortisone 10mg tablets cannot be used, either whole or halved, to administer the required dose.

Dosing reduction required for concomitant use of specific Strong CYP3A4 or OATP inhibitors drugs.

Dosing reduction required for concomitant use of specific Strong CYP3A4 or OATP inhibitors drugs.

RCHT Renal Team prefers Adoport brand of Tacrolimus

Aripiprazole prolonged release suspension for injection (Abilify Maintena) is accepted onto the formulary. Patients have to be stabilised on this depot injection for up to 3 months prior to CPFT requesting GPs to take over prescribing responsibility.

Alkindi is accepted for cortisol replacement therapy of infants and young children with adrenal insufficiency where the hydrocortisone 10mg tablets cannot be used, either whole or halved, to administer the required dose.

Antacid and oxetacaine suspension contains a local anaesthetic and is useful post radiotherapy and for topical analgesia in very severe painful oesophagitis.